Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2013 2014 2015 2016

Details for Mechanism ID: 12845
Country/Region: Ukraine
Year: 2013
Main Partner: Chemonics International
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $1,100,000

This new TB project is being procured via the USAID TASC 2 IQC. The project will assist the MoH to decrease the TB burden by reducing TB morbidity and mortality, and enable the GoU (in partnership with other stakeholders) to implement effective and strategic actions to improve quality of TB services, including the prevention, detection and treatment of TB, MDR TB and XDR TB, as well as the prevention of rapid growth in the rate of TB/HIV co-infection.

The purpose of this program is to improve the quality and expand the availability of WHO-recommended DOTS-based TB services; create a safer medical environment in TB/HIV settings by improving infection control standards and practices; build the capacity to implement programmatic management of drug resistant TB; and improve access to TB/HIV co-infection services in 10 USAID-supported regions over the first two years. By the end of year two, following an external evaluation, the project will expand services to two other regions with high or medium TB burden. The project will contribute to the USG strategy for HSS in service delivery quality, and national, regional, and local leadership in health care. The activity complements the GF TB project and will work closely with them to leverage these additional resources.

The new project will work closely with GoU and WHO, which are leading and coordinating the anti-TB program. This project will provide TA to reach TB/HIV co-infected patients and support the goals of USAIDs other health projects in HIV and family planning by reinforcing messages related to prevention of disease transmission and appropriate Tx and follow-up. The project contributes to Partnership Framework goals and objectives and supports the GHI principle related to sustainability and quality services.

Funding for Care: TB/HIV (HVTB): $1,100,000

This project is under procurement. The budget code narrative can be updated upon award and after development of the project's first year workplan.

Objectives under this project include improving the quality and availability of WHO-recommended DOTS- based TB services through building institutional capacity to provide quality services. Activities include updating the formal medical education system, establishing a TB training resource center, and strengthening TB M&E and surveillance. Other activities include expanding access to TB services, and conducting operations research to strengthen the National TB Program's performance. The project will work with the Ministry of Health to strengthen a safer medical environment in TB and HIV settings by improving infection control standards and practices and strengthening capacity to oversee and evaluate infection control interventions.

Project activities will also align to Ukraine's Partnership Framework and national TB/HIV policies. The winning applicant will coordinate project planning and implementation with the Ministry of Health, Global Fund, and other partners providing TB/HIV technical assistance. The project is designed to strengthen the capacity of the Ukrainian public sector to upgrade and oversee a state-of-the-art national TB/HIV response. Technical approaches include inculcating technical standards and approaches through the formal medical education system while working with the Ukrainian Ministry of Health to directly implement protocols and procedures that align to WHO's international standards in TB/HIV and infection control. The winning applicant will propose an M&E approach that reports high-quality data using the national TB/HIV M&E framework, as well as report progress against project indicators.

Subpartners Total: $0
Project HOPE: NA
Cross Cutting Budget Categories and Known Amounts Total: $620,000
Gender: Gender Equality $20,000
Human Resources for Health $600,000